About: Prabodh kumar Kandala
- Website
- http://prabodhkandala.wordpress.com
- Details
- I am a pharmaceutical research scientist. I like to talk to people, listen to their problems and help them if needed. I like to motivate people. I sing, dance, write poems etc. I love to blog as well.
Posts by Prabodh kumar Kandala:
-
July 29, 2012 Men With Prostate Cancer More Likely to Die from Other Causes
-
July 29, 2012 Discovery of New White Blood Cell Reveals Target for Better Vaccine Design
-
July 29, 2012 Tumor Cells’ Inner Workings Predict Cancer Progression
-
July 8, 2012 Zebrafish Provide Insights Into Causes and Treatment of Human Diseases
-
July 8, 2012 Melanoma: Molecule in Immune System Could Help Treat Dangerous Skin Cancer
-
July 8, 2012 Transcription Factor Lyl-1 Critical in Producing Early T-Cell Progenitors
-
May 31, 2012 First Epigenome in Europe Completed
-
May 30, 2012 New Anti-Cancer Drug Developed
-
May 30, 2012 Children Exposed to the Common Pollutant Naphthalene Show Signs of Chromosomal Damage
-
May 30, 2012 Commonly Used Painkillers May Protect Against Skin Cancer
Follow Blog via Email
Join 2,041 other subscribers-
Recent Posts
- FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
- Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
- In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
- Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
- AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
- In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
- Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
- 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
- Protected: KOL on Competitive Dynamics: LPBI Group’s Founder’s Radar Screens on AI-in-Health, Life Sciences & BioPharma June 15, 2026
- Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026
Archives
Categories
Meta